These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 26391185)
1. The contribution of white matter lesions (WML) to Parkinson's disease cognitive impairment symptoms: A critical review of the literature. Veselý B; Rektor I Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S166-70. PubMed ID: 26391185 [TBL] [Abstract][Full Text] [Related]
2. Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease. Stojkovic T; Stefanova E; Soldatovic I; Markovic V; Stankovic I; Petrovic I; Agosta F; Galantucci S; Filippi M; Kostic V J Neurol; 2018 Jun; 265(6):1320-1327. PubMed ID: 29572571 [TBL] [Abstract][Full Text] [Related]
3. The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature. Veselý B; Antonini A; Rektor I J Neural Transm (Vienna); 2016 Mar; 123(3):241-50. PubMed ID: 26483133 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal brain volumetric changes and their predictive effects on cognition among cognitively asymptomatic patients with Parkinson's disease. Wen MC; Ng A; Chander RJ; Au WL; Tan LC; Kandiah N Parkinsonism Relat Disord; 2015 May; 21(5):483-8. PubMed ID: 25753847 [TBL] [Abstract][Full Text] [Related]
5. The impact of white matter lesions on the cognitive outcome of subthalamic nucleus deep brain stimulation in Parkinson's disease. Blume J; Lange M; Rothenfusser E; Doenitz C; Bogdahn U; Brawanski A; Schlaier J Clin Neurol Neurosurg; 2017 Aug; 159():87-92. PubMed ID: 28582689 [TBL] [Abstract][Full Text] [Related]
6. Impact of regional white matter lesions on cognitive function in subcortical vascular cognitive impairment. Ai Q; Pu YH; Sy C; Liu LP; Gao PY Neurol Res; 2014 May; 36(5):434-43. PubMed ID: 24641691 [TBL] [Abstract][Full Text] [Related]
7. Differential spatial distribution of white matter lesions in Parkinson's and Alzheimer's diseases and cognitive sequelae. Grey MT; Mitterová K; Gajdoš M; Uher R; Klobušiaková P; Rektorová I; Rektor I J Neural Transm (Vienna); 2022 Aug; 129(8):1023-1030. PubMed ID: 35819634 [TBL] [Abstract][Full Text] [Related]
8. Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment. Heinrich J; Vidal JS; Simon A; Rigaud AS; Hanon O; Epelbaum J; Viollet C; Duron E J Alzheimers Dis; 2018; 61(3):1133-1141. PubMed ID: 29332036 [TBL] [Abstract][Full Text] [Related]
9. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease. Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277 [TBL] [Abstract][Full Text] [Related]
10. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease. Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835 [TBL] [Abstract][Full Text] [Related]
11. Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease. Defrancesco M; Marksteiner J; Deisenhammer E; Kemmler G; Djurdjevic T; Schocke M J Alzheimers Dis; 2013; 34(3):665-72. PubMed ID: 23254639 [TBL] [Abstract][Full Text] [Related]
12. Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study. Kalbe E; Rehberg SP; Heber I; Kronenbuerger M; Schulz JB; Storch A; Linse K; Schneider C; Gräber S; Liepelt-Scarfone I; Berg D; Dams J; Balzer-Geldsetzer M; Hilker R; Oberschmidt C; Witt K; Schmidt N; Mollenhauer B; Trenkwalder C; Spottke A; Roeske S; Wittchen HU; Riedel O; Dodel R J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1099-105. PubMed ID: 27401782 [TBL] [Abstract][Full Text] [Related]
13. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment. Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006 [TBL] [Abstract][Full Text] [Related]
14. Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment. Korczyn AD Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S159-61. PubMed ID: 26516060 [TBL] [Abstract][Full Text] [Related]